Our Partnerships and Collaborations

OncoNano has substantial experience with multiple payloads:

  • Bi-specific and monoclonal antibodies
  • Cytokines
  • Fusion proteins
  • Small molecules

Please contact us if there are any payloads in your pipeline that can benefit from:

  • Reduced systemic toxicity
  • Improved therapeutic index
  • Direct payloads delivery and subsequent conditional release at the TME

Contact Us

Headquarters

OncoNano Medicine Inc.

181 Grand Ave, Ste 225

Southlake, Texas 76092, US

For more information on possible partnerships or collaborations, contact Elina Lavit at the following address:

elavit@onconanomed.com

QUICK CONTACT